324
Y. Liu et al. / Dyes and Pigments 95 (2012) 322e329
a Heraus CHN-rapid elemental analyzer. Thermogravimetric anal-
yses (TGA) were performed under a nitrogen atmosphere at
a heating rate of 20 ꢀC/min using a Perkin-Elmer TGA-7 thermal
analyzer. The FT-IR spectra were obtained on a Perkin-Elmer
spectrum one Fourier transform infrared spectrometer (KBr
pellet). Ultravioletevisible (UV-vis) spectra were measured with
a Lambda 25 spectrophotometer. Photoluminescence (PL) spectra
were conducted on a Perkin-Elmer LS55 lumine-scent spectrom-
eter with a xenon lamp as a light source. Cyclic voltammetry was
carried out on a CHI660A electrochemical workstation in a DCM
solution of tetrabutylammonium hexafluorophosphate (Bu4NPF6)
(0.1 M) with a scan rate of 50 mV/s at room temperature (RT) under
nitrogen flow protection.
The single-layer PLEDs with a typical architecture of ITO/
PEDOT:PSS (50 nm)/PVK-PBD (30 wt %): europium (III) complex/LiF
(0.5 nm)/Al (150 nm) were initially fabricated. The doping concen-
trations of the europium (III) complex varied from 1 wt %, 2 wt%, 4 wt
% to 8 wt %. In the devices, ITO is used as the anode, poly(3,4-
ethylenedioxythiophene):poly(styrenesulfonate) (PEDOT:PSS) is
used as a hole-injection layer, and LiF/Al is employed as a cathode.
The emitting-layer consists of europium (III) complexes and the
PVK-PBD blend. The weight ratio of PBD is 30% in the blend.
Mp: 125.0e127.0 ꢀC. 1H NMR(400 MHz, CDCl3, TMS, dppm):
8.13e8.10 (m, 4H), 8.05e8.03 (d, J ¼ 8.6 Hz, 2H), 7.47e7.43 (m, 4H),
7.25e7.22 (m, 4H), 6.98e6.96 (d, J ¼ 8.4 Hz, 2H), 4.37e4.33 (t, 2H),
4.00e3.97 (t, 2H), 1.96e1.93 (t, 2H), 1.81e1.77 (t, 2H), 1.53e1.47
(m, 4H).
2.2.5. Synthesis of 9-(6-(4-(5-(4-tert-butylphenyl)-1,3,4-oxadiazol-
2-yl)phenoxy)hexyl)-9H-carbazole-3,6-dicarbaldehyde
[ButPhOXD6Cz(CHO)2]
Phosphoryl chloride (4.39 g, 29.0 mmol) was added dropwise to
a mixture of DMF (3.8 mL) and 1,2-dichloroethane (3.0 mL) at 0 ꢀC.
ButPhOXD6Cz (0.76 g, 1.4 mmol) was then added under a vigorously
stirring and the resulting mixture was reacted for 48 h at 90 ꢀC.
After cooled to RT, the mixture was poured into distilled water
(50 mL) and extracted with chloroform (3 ꢁ 50 mL). The combined
organic layer was dried over anhydrous MgSO4 and filtered. The
filtrate was distilled under reduced pressure to remove the solvent,
and the residue was purified by silica-gel column chromatography
using DCM/ethyl acetate (V/V ¼ 15:1) as eluent to provide a yellow
powder (0.37 g) with a yield of 45%. Mp: 128e130 ꢀC. 1H NMR
(400 MHz, CDCl3), d (ppm): 10.13 (s, 2H), 8.67 (s, 2H), 8.10e8.03 (m,
6H), 7.57e7.55 (t, J ¼ 4.2 Hz, 4H), 6.97e6.95 (d, J ¼ 8.0 Hz, 2H),
4.44e4.41 (t, J ¼ 6.4 Hz, 2H), 3.99e3.98 (t, J ¼ 3.2 Hz, 2H), 2.04e1.96
(m, 4H), 1.81e1.77 (m, 4H), 1.37 (s, 9H).
2.2. Synthesis of ligands and complexes
2.2.1. Synthesis of 9-(6-(4-(5-(4-tert-butylphenyl)-1,3,4-oxadiazol-
2-yl)phenoxy)hexyl)-9H-carbazole [ButPhOXD6Cz]
2.2.6. Synthesis of 9-(6-(4-(5-p-tolyl-1,3,4-oxadiazol-2-yl)
phenoxy)hexyl)-9H-carbazole-3,6-dicarbaldehyde
2-(4-Hydroxyohenyl)-5-(4-4-tert-butylphenyl)-1,3,4-
[CH3PhOXD6Cz(CHO)2]
oxadiazole (2.7 g, 10 mmol), 6-bromo-hexyl-9-H-carbazole (1.8 g,
8.8 mmol), K2CO3 (4.4 g, 30.0 mmol), DMF (35 mL) and KI (0.1 g)
were stirred at 100 ꢀC for 24 h under nitrogen atmosphere. The
resulting mixture was cooled to RT, poured into water (50 mL) and
then extracted with DCM (3 ꢁ 50 mL). The combined organic layer
was dried over anhydrous MgSO4 and filtered. The filtrate was
evaporated to remove the solvent and the residue was purified by
silica-gel column chromatography using petroleum ether/ethyl
acetate (V/V ¼ 5: 1) as eluent to provide a white solid (1.7 g) with
a yield of 60%. Mp: 118.0e119.0 ꢀC. 1H NMR(400 MHz, CDCl3, TMS,
dppm): 8.12e8.10 (d, J ¼ 8.4 Hz, 2H), 8.05e8.03 (m, 4H), 7.55e7.53 (d,
J ¼ 8.4 Hz, 2H), 7.46e7.40 (m, 4H), 7.23e7.25 (d, J ¼ 8.4 Hz, 2H),
6.97e6.95 (d, J ¼ 8.5 Hz, 2H), 4.36e4.33 (t, 2H), 4.00e3.96 (t, 2H),
1.98e1.75 (m, 4H), 1.58e1.48 (m, 4H), 1.37 (s, 9H).
CH3PhOXD6Cz(CHO)2 was prepared according to the synthetic
procedure of ButPhOXD6Cz(CHO)2. A yellow solid was obtained
with a yield of 43%. Mp: 129e130 ꢀC. 1H NMR (400 MHz, CDCl3),
d
(ppm): 10.14 (s, 2H), 8.68 (s, 2H), 8.11e8.00 (m, 6H), 7.58e7.56 (d,
J ¼ 8.2 Hz, 2H), 7.34e7.32 (d, J ¼ 8.0 Hz, 2H) 6.99e6.97 (d, J ¼ 8.8 Hz,
2H), 4.45e4.31 (t, J ¼ 8.4 Hz, 2H), 4.01e3.98 (t, J ¼ 6.2 Hz, 2H), 2.44
(s, 3H), 2.00e1.78 (m, 4H), 1.60e1.49 (m, 4H).
2.2.7. Synthesis of 9-(6-(4-(5-(4-methoxyphenyl)-1,3,4-oxadiazol-
2-yl)phenoxy)hexyl)-9H-carbazole-3,6-dicarbaldehyde
[MeOPhOXD6Cz(CHO)2]
MeOPhOXD6Cz(CHO)2 was prepared according to the synthetic
procedure of ButPhOXD6Cz(CHO)2. A yellow solid was obtained
with a yield of 42%. Mp: 131e132 ꢀC. 1H NMR(400 MHz, CDCl3),
d
(ppm): 10.14 (s, 2H), 8.68 (s, 2H), 8.11e8.02 (m, 6H), 7.58e7.56 (d,
2.2.2. Synthesis of 9-(6-(4-(5-(4-methylphenyl)-1,3,4-oxadiazol-2-
yl)phenoxy)hexyl)-9H-carbazole [MePhOXD6Cz]
J ¼ 8.4 Hz, 2H), 7.04e7.02 (d, J ¼ 8.8 Hz, 2H), 6.97e6.95 (d, J ¼ 8.4 Hz,
2H), 4.45e4.41 (t, J ¼ 8.6 Hz, 2H), 4.01e3.98 (t, J ¼ 6.6 Hz, 2H), 3.89
(s, 3H), 2.05e1.78 (m, 4H), 1.82e1.75 (m, 4H), 1.61e1.49 (m, 4H).
MePhOXD6Cz was prepared according to the synthetic proce-
dure of ButPhOXD6Cz. A white solid was obtained with a yield of
58%. Mp: 122.0e123.0 ꢀC. 1H NMR(400 MHz, CDCl3, TMS, dppm):
8.12e8.02 (m, 6H), 7.47e7.41 (m, 4H), 7.26e7.23 (d, J ¼ 9.4 Hz, 2H),
7.04e6.95 (m, 4H), 4.59e4.33 (t, 2H), 4.00e3.96 (t, 2H), 2.44 (s, 3H),
1.98e1.75 (m, 4H), 1.58e1.47 (m, 4H).
2.2.8. Synthesis of 9-(6-(4-(5-(4-fluorophenyl)-1,3,4-oxadiazol-2-
yl)phenoxy)hexyl)-9H-carbazole-3,6-dicarbaldehyde
[FPhOXD6Cz(CHO)2]
FPhOXD6Cz(CHO)2 was prepared according to the synthetic
procedure of ButPhOXD6Cz(CHO)2. A yellow solid was obtained
with a yield of 44%. Mp: 127e128 ꢀC. 1H NMR (400 MHz, CDCl3),
2.2.3. Synthesis of 9-(6-(4-(5-(4-methoxyphenyl)-1,3,4-oxadiazol-
2-yl)phenoxy)hexyl)-9H-carbazole [MeOPhOXD6Cz]
d
(ppm): 10.16 (s, 2H), 8.70 (s, 2H), 8.15e8.04 (m, 6H), 7.59e7.57 (d,
MeOPhOXD6Cz was prepared according to the synthetic
procedure of ButPhOXD6Cz. A white solid was obtained with a yield
of 60%. Mp: 122.0e123.0 ꢀC. 1H NMR(400 MHz, CDCl3, TMS, dppm):
8.12e8.02 (m, 6H), 7.47e7.41 (m, 4H), 7.26e7.23 (d, J ¼ 9.4 Hz, 2H),
7.04e6.95 (m, 4H), 4.36e4.33 (t, 2H), 4.00e3.96 (t, 2H), 3.89 (s, 3H),
1.98e1.75 (m, 4H), 1.58e1.47 (m, 4H).
J ¼ 8.4 Hz, 2H), 7.24e7.22 (d, J ¼ 8.4 Hz, 2H), 6.99e6.97 (d,
J ¼ 8.4 Hz, 2H), 4.47e4.43 (t, J ¼ 8.2 Hz, 2H), 4.03e4.00 (t, J ¼ 6.2 Hz,
2H), 2.01e1.80 (m, 4H), 1.56e1.49 (m, 4H).
2.2.9. Synthesis of ButPhOXD6CzPhen2
ButPhOXD6Cz(CHO)2 (0.3 g, 0.5 mmol) dissolved in CHCl3
(20 mL) and a catalytic amount of acetic acid were mixed under
stirring for about 20 min 5-amino-1,10-phenanthroline (0.23 g,
1.2 mmol) dissolved in CHCl3 (25 mL) was then added dropwise.
The resulting mixture was refluxed for another 24 h under nitrogen
protection and distilled to remove excess chloroform under
2.2.4. Synthesis of 9-(6-(4-(5-(4-fluorophenyl)-1,3,4-oxadiazol-2-
yl)phenoxy)hexyl)-9H-carbazole [FPhOXD6Cz]
FPhOXD6Cz was prepared according to the synthetic procedure
of ButPhOXD6Cz. A white solid was obtained with a yield of 60%.